R Rubin

39 papers receiving 4.0k citations

Peers

R Rubin
Comparison fields: 5 of 101
  • Endocrinology, Diabetes and Metabolism 1.6k
  • Hepatology 423
  • Cancer Research 676
  • Molecular Biology 2.0k
  • Epidemiology 659
Replace Leslie B. Rall with:
Leslie B. Rall United States
Béatrice Parfait France
Mathilde Sibony France
Dimitris Kardassis Greece
Reid Huber United States
Marco Pontoglio France
Stefania Gelmini Italy
Ingrid Laurendeau France
Timothy J. Knott United Kingdom
Noreen Luetteke United States
R Rubin relative to Leslie B. Rall United States Leslie B. Rall's profile →
Citations per field
00.5×4.5×
Leslie B. Rall · 1×
Citations per year

Countries citing papers authored by R Rubin

Since Specialization
Citations

This map shows the geographic impact of R Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Rubin more than expected).

Fields of papers citing papers by R Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Rubin. The network helps show where R Rubin may publish in the future.

Co-authors

The 25 scholars most cited alongside R Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R Rubin Line = papers co-authored together R Rubin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1993461
2 1994448
3
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003439
4
The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
1995323
5
Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
1995270
6
Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.
1994269
7
Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.
1995248
8 1994245
9 1987174
10
Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
1995116
11 1985102
12 199186
13 199386
14
Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells.
199485
15
Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines.
199381
16
AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal.
199776
17 199173
18 199464
19 198864
20 199643

About R Rubin

R Rubin is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Epidemiology and Hepatology, having authored 39 papers that have together received 4.0k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (11 papers), Liver Disease Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Pancreatic function and diabetes (3 papers), Hepatitis B Virus Studies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Hepatology (423 citations), Cancer Research (676 citations), Molecular Biology (2.0k citations) and Epidemiology (659 citations). R Rubin has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Renato Baserga, Christian Sell, Mariana Resnicoff, Domenico Coppola, Michele Rubini, Argiris Efstratiadis, Jan B. Hoek, Masahiko Miura, Andrew P. Thomas and Catherine Deveaud. Their work appears in journals such as Radiology, Journal of Biological Chemistry, Biochemical Journal, Molecular and Cellular Biology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact